The U.S. government is trying to secure 100 million additional doses of Pfizer Inc's coronavirus vaccine, the Financial Times reported on Friday, citing people familiar with the order.
AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief adviser for the U.S. government's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback